News

January 25, 2017 - Johns Hopkins and AAMI publish on implementation of ViSi Mobile System Read More

January 9, 2017 - CoMentis and Anvyl Announce the Initiation of Clinical Trials for APN1126 fo the Treatment of Schizophrenia Read More

January 6, 2017 - Calcimedica Initiates Phase 1 Clinical Studies For CRAC Channel Inhibitor Read More

January 4, 2017 - Twenty-two Patients are Added to ViaCyte’s Intellectual Property Portfolio Read More

January 1, 2017 - Recordings available from 2016 AAMI Foundation Event Read More

December 7, 2016 - Codman Neuro Announces Acquisition Of Pulsar Vascular Inc., Expanding Neurovascular Treatment For Patients With Complex Aneurysms Read More

November 17, 2016 - Diazon Pharmaceutical’s anti-cancer agent DZ-2384 mechanism for high activity and low neurotoxicity published by McGill researchers in Science Translational Medicine Read More

November 16, 2016 - Glycomine, Inc. Announces $12 Million Series A Financing to Advance a New Generation of Replacement Therapies for Rare Diseases Read More

November 15, 2016 - San Francisco VA, UCSF And CalciMedica, Inc. Present Results On CRAC Channel Inhibitors In Traumatic Brain Injury Model At Neuroscience Meeting Read More

November 14, 2016 - CalciMedica Announces Senior Clinical Development Hire Read More